Review
Sep 2026
Tumor resistance to protein kinase inhibitors.
Reviewing Epidermal Growth Factor Receptor (EGFR) T790M and BCR::ABL1 T315I mutations reveals that the important interactions and binding sites are removed or obstructed with the drug.
Mridul Singh Sengar, Ajita Paliwal, Niranjan Kaushik et al.
· Journal of chemotherapy · 0 citations